Page 2 - ஜெநெரிக் பெயர் துணை ஆர்கநைஸேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெநெரிக் பெயர் துணை ஆர்கநைஸேஶந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெநெரிக் பெயர் துணை ஆர்கநைஸேஶந் Today - Breaking & Trending Today

DRAP directive to provinces: 'Ensure doctors prescribed drugs with generic names'


National
April 19, 2021
LAHORE: The Drug Regulatory Authority of Pakistan (DRAP) has directed all provincial governments to ensure that doctors prescribe medicines with their generic names in public and private sector in the country.
The DRAP issued the order in response to public complaints on PM’s citizens’ portal against pharmaceutical companies and doctors’ collusion to rip off of the people through prescription and sale of costlier medicines under brand name.
In a letter to secretaries of health departments of all four provinces, Azad Jammu Kashmir (AJK) and Gilgit-Baltistan (GB) and Commissioner of Islamabad Capital Territory (ICT), DRAP’s Director Pharmacy Services Dr Abdur Rasheed said the citizens had complained through Prime Minister’s Performance Delivery Unit (PMDU) against company-influenced brand-based prescription of medicines by doctors in government and private sectors. This practice adds to the economic burden of the country, and also p ....

Islamabad Capital Territory , Gilgit Baltistan , Northern Areas , Noor Mahar , Drug Regulatory Authority Of Pakistan , Drug Lawyer Forum , Pharmacy Services Dr Abdur Rasheed , Drug Regulatory Authority , Azad Jammu Kashmir , Prime Minister , Performance Delivery Unit , Drug Act , இஸ்லாமாபாத் மூலதனம் பிரதேசம் , வடக்கு பகுதிகள் , மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் , மருந்து வழக்கறிஞர் மன்றம் , மருந்து ஒழுங்குமுறை அதிகாரம் , அசாத் ஜம்மு காஷ்மீர் , ப்ரைம் அமைச்சர் , செயல்திறன் டெலிவரி அலகு , மருந்து நாடகம் ,

DRAP directive to provinces: 'Ensure doctor prescribed drug with generic names'


National
April 19, 2021
LAHORE: The Drug Regulatory Authority of Pakistan (DRAP) has directed all provincial governments to ensure that doctors prescribe medicines with their generic names in public and private sector in the country.
The DRAP issued the order in response to public complaints on PM’s citizens’ portal against pharmaceutical companies and doctors’ collusion to rip off of the people through prescription and sale of costlier medicines under brand name.
In a letter to secretaries of health departments of all four provinces, Azad Jammu Kashmir (AJK) and Gilgit-Baltistan (GB) and Commissioner of Islamabad Capital Territory (ICT), DRAP’s Director Pharmacy Services Dr Abdur Rasheed said the citizens had complained through Prime Minister’s Performance Delivery Unit (PMDU) against company-influenced brand-based prescription of medicines by doctors in government and private sectors. This practice adds to the economic burden of the country, and also p ....

Islamabad Capital Territory , Gilgit Baltistan , Northern Areas , Noor Mahar , Drug Regulatory Authority Of Pakistan , Drug Lawyer Forum , Pharmacy Services Dr Abdur Rasheed , Drug Regulatory Authority , Azad Jammu Kashmir , Prime Minister , Performance Delivery Unit , Drug Act , இஸ்லாமாபாத் மூலதனம் பிரதேசம் , வடக்கு பகுதிகள் , மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் , மருந்து வழக்கறிஞர் மன்றம் , மருந்து ஒழுங்குமுறை அதிகாரம் , அசாத் ஜம்மு காஷ்மீர் , ப்ரைம் அமைச்சர் , செயல்திறன் டெலிவரி அலகு , மருந்து நாடகம் ,

DRAP directive to provinces: 'Ensure doctors prescribe drugs with generic names'


Top Story
April 19, 2021
LAHORE: The Drug Regulatory Authority of Pakistan (DRAP) has directed all provincial governments to ensure that doctors prescribe medicines with their generic names in public and private sector in the country.
The DRAP issued the order in response to public complaints on PM’s citizens’ portal against pharmaceutical companies and doctors’ collusion to rip off of the people through prescription and sale of costlier medicines under brand name.
In a letter to secretaries of health departments of all four provinces, Azad Jammu Kashmir (AJK) and Gilgit-Baltistan (GB) and Commissioner of Islamabad Capital Territory (ICT), DRAP’s Director Pharmacy Services Dr Abdur Rasheed said the citizens had complained through Prime Minister’s Performance Delivery Unit (PMDU) against company-influenced brand-based prescription of medicines by doctors in government and private sectors. This practice adds to the economic burden of the country, and also ....

Islamabad Capital Territory , Gilgit Baltistan , Northern Areas , Noor Mahar , Drug Regulatory Authority Of Pakistan , Drug Lawyer Forum , Pharmacy Services Dr Abdur Rasheed , Drug Regulatory Authority , Azad Jammu Kashmir , Prime Minister , Performance Delivery Unit , Drug Act , இஸ்லாமாபாத் மூலதனம் பிரதேசம் , வடக்கு பகுதிகள் , மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் , மருந்து வழக்கறிஞர் மன்றம் , மருந்து ஒழுங்குமுறை அதிகாரம் , அசாத் ஜம்மு காஷ்மீர் , ப்ரைம் அமைச்சர் , செயல்திறன் டெலிவரி அலகு , மருந்து நாடகம் ,

Panacea Biotec to produce 100 mn annual doses of Sputnik V in India


The Russian Direct Investment Fund (RDIF, Russia s sovereign wealth fund), and Panacea Biotec announced cooperation to produce 100 million doses per year of Sputnik V, the world s first registered vaccine against coronavirus.
Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF.
To date Sputnik V has been registered in 59 countries globally with total population of over 1.5 billion people.
Efficacy of Sputnik V is 91.6% as confirmed by the data published in the Lancet, one of the world s oldest and most respected medical journals.
The vaccine is based on a proven and well-studied platform of human adenoviral vectors and uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots. ....

Russian Direct Investment Fund , Panacea Biotec , Capital Market , Covid 19 Vaccines , Clinical Trials , Mo Ney , Covid 19 Pandemic In Russia , Science And Technology In Russia , Sputnikv Covid 19 Vaccine , Sovereign Wealth Fund , ரஷ்ய நேரடி முதலீடு நிதி , சஞ்சீவி பயோடெக் , மூலதனம் சந்தை , மருத்துவ சோதனைகள் , அறிவியல் மற்றும் தொழில்நுட்பம் இல் ரஷ்யா , இறையாண்மை செல்வம் நிதி ,